Axon Enterprise, Inc.

What they do

Axon develops and sells an integrated ecosystem of hardware and cloud software, including TASER conducted energy devices, body and in-car cameras, drones and counter-drone systems, and cloud platforms such as Axon Evidence and Axon Records. Following a 2025 realignment, it reports in two segments: Software and Services and Connected Devices. Annual recurring revenue reached $1.3 billion as of December 31, 2025.

Revenue drivers

• Software and Services — Cloud SaaS subscriptions for digital evidence management, records, productivity and AI tools, plus professional services and on-premise licenses. Q2 2026 revenue was $398 million, up 36% year over year.
• Connected Devices — Hardware including TASER CEDs, body and in-car cameras, drones and counter-drone products, accessories and extended warranties. Q2 2026 revenue was $507 million, about 56% of net sales, up 35% year over year.
• AI Era Plan — Premium software offering that bundles AI capabilities such as Draft One and Real-Time Translation; management said AI Era revenue grew nearly 700% year over year in Q2 2026.
• Dedrone — Counter-drone technology within Connected Devices; management reported Dedrone revenue surpassed $100 million.

Recent performance

Q2 2026 revenue was $904.4 million, up 35.3% year over year, with income from operations of $46.8 million versus a $1.0 million operating loss a year earlier. Gross margin was 60.4% and adjusted gross margin 62.9%, down from 63.3%, on a higher mix of professional services revenue and scaling new products, partly offset by tariff refunds. Net income was $29.4 million. Six-month 2026 revenue was $1.7 billion, up 34.6%, with net income of $198.7 million including $202.3 million of net gains on strategic investments.

Strategy

Axon frames its strategy as building the operating system for public safety, connecting cameras, drones, 911 systems, software and AI into one network so added devices and data make the platform more valuable. Management said future contracted bookings grew 41% year over year to $15.1 billion, citing two nine-figure agreements with major U.S. cities, two eight-figure state corrections agreements and a first full-scope Axon 911 customer agreement. International and enterprise bookings each roughly tripled year over year. It is investing in headcount, AI and new product offerings, and is now disclosing new contract bookings on a five-year normalized basis.

Risks

• Law enforcement demand dependence — The business substantially depends on continued acceptance of its products by law enforcement agencies worldwide, so reduced demand would materially hurt results.
• Concentration in CEDs — Axon substantially depends on TASER conducted energy device sales, and loss of broad acceptance would diminish growth prospects and financial condition.
• New product execution — Failure to successfully design, introduce, sell and deploy new products or features, or delays in development schedules, could adversely affect revenue and cash flows.
• Data security and AI uncertainty — A breach of its or its third-party cloud providers' security, or uncertainty in the development, deployment and use of AI in its products, could undermine customer confidence and create legal and financial exposure.

Outlook

Management raised its full-year 2026 revenue growth outlook to 32% to 34% from 30% to 32% previously. It maintained an Adjusted EBITDA margin outlook of approximately 25.5%. In Q2 2026, Adjusted EBITDA was $242 million, a 26.8% margin, and management cited 10 consecutive quarters of revenue growth above 30%.